The Effects of ADHD Medication (TEAM) Study

PHASE4CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

January 12, 2015

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2021

Conditions
ADHD
Interventions
DRUG

OROS-Methylphenidate (MPH)

OROS-methylphenidate will be taken orally once daily at doses that have been approved for the study age group by the U.S. FDA.

Trial Locations (2)

45229

Children's Hospital Medical Center, Cincinnati

98105

Seattle Children's Hospital, Seattle

All Listed Sponsors
collaborator

Seattle Children's Hospital

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT02293655 - The Effects of ADHD Medication (TEAM) Study | Biotech Hunter | Biotech Hunter